Cargando…
Serum Chemerin Levels Are Associated with Abdominal Visceral Fat in Type 2 Diabetes
Chemerin is a recently identified adipokine suggested to play a role in obesity and its metabolic complications. The relationship between visceral obesity and serum chemerin levels in type 2 diabetes (T2DM) is unknown and may differ from that of subjects without diabetes. Therefore, we evaluated whe...
Autores principales: | Han, Juyoung, Kim, So Hun, Suh, Young Ju, Lim, Hyun Ae, Shin, Heekyoung, Cho, Soon Gu, Kim, Chei Won, Lee, Seung Youn, Lee, Dae Hyung, Hong, Seongbin, Kim, Yong Seong, Nam, Moon-Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853672/ https://www.ncbi.nlm.nih.gov/pubmed/27247502 http://dx.doi.org/10.3346/jkms.2016.31.6.924 |
Ejemplares similares
-
Serum Chemerin Levels are Associated with Visceral Adiposity, Independent of Waist Circumference, in Newly Diagnosed Type 2 Diabetic Subjects
por: Cheon, Dae Young, et al.
Publicado: (2017) -
The Effect of Abdominal Visceral Fat, Circulating Inflammatory Cytokines, and Leptin Levels on Reflux Esophagitis
por: Nam, Su Youn, et al.
Publicado: (2015) -
Impact of Socioeconomic Status on Health Behaviors, Metabolic Control, and Chronic Complications in Type 2 Diabetes Mellitus
por: Kim, So Hun, et al.
Publicado: (2018) -
Effect of Abdominal Visceral Fat Change on the Regression of Erosive Esophagitis: A Prospective Cohort Study
por: Nam, Su Youn, et al.
Publicado: (2019) -
Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma
por: Kim, Chei Won, et al.
Publicado: (2015)